{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:42:40Z","timestamp":1789879360908,"version":"4.0.1"},"reference-count":69,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T00:00:00Z","timestamp":1369872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>In 2006\/2007, two vaccines were licensed against two of the most common HPV types that cause about 70% of cervical cancers. Clinical trials show that vaccinated individuals develop high levels of neutralizing antibodies. Although these data suggest that serum antibodies are the mode of action against HPV infection, it is uncertain whether immune responses generated by vaccination are similar to those induced by a natural infection. In this review, the current knowledge of humoral immune responses after natural infection and vaccination is described. Serosurveillance can be used as a monitoring tool to study vaccine uptake, the impact of HPV16\/18 vaccination on other HPV types, dynamics of HPV infection and herd\u2010immunity. In addition, factors that contribute to a higher seroresponse after a natural infection, which are summarized in this article (a persistent DNA infection, increased viral load, immunosuppression and high sexual risk behavior), can help to interpret these indirect effects better. <jats:bold><jats:italic>J. Med. Virol. 85:1379\u20131385, 2013<\/jats:italic><\/jats:bold>. \u00a9 2013 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jmv.23616","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T22:58:33Z","timestamp":1369954713000},"page":"1379-1385","source":"Crossref","is-referenced-by-count":32,"title":["Review: Current knowledge on the role of HPV antibodies after natural infection and vaccination: Implications for monitoring an HPV vaccination programme"],"prefix":"10.1002","volume":"85","author":[{"given":"Madelief","family":"Mollers","sequence":"first","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM) Centre for Infectious Disease Control Bilthoven The Netherlands"},{"name":"Department of Pathology VU University Medical Centre (VUmc) Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanique M.","family":"Vossen","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM) Centre for Infectious Disease Control Bilthoven The Netherlands"},{"name":"Department of Pathology VU University Medical Centre (VUmc) Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirte","family":"Scherpenisse","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM) Centre for Infectious Disease Control Bilthoven The Netherlands"},{"name":"Department of Pathology VU University Medical Centre (VUmc) Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R.M.","family":"van der Klis","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM) Centre for Infectious Disease Control Bilthoven The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.L.M.","family":"Meijer","sequence":"additional","affiliation":[{"name":"Department of Pathology VU University Medical Centre (VUmc) Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM) Centre for Infectious Disease Control Bilthoven The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,30]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.008"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/426867"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/657321"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.5.927"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/315498"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.185"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0349"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.01.011"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.9.630"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70158-5"},{"key":"e_1_2_5_12_1","first-page":"425","article-title":"Correlation between direct Elisa, single epitope\u2010based inhibition elisa and pseudovirion\u2010based neutralization assay for measuring anti\u2010HPV\u201016 and anti\u2010HPV\u201018 antibody response after vaccination with the AS04\u2010adjuvanted HPV\u201016\/18 cervical cancer vaccine","volume":"4","author":"Dessy F","year":"2008","journal-title":"HumVaccin"},{"key":"e_1_2_5_13_1","first-page":"959","article-title":"Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human","volume":"12","author":"Dias D","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03384.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.006"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.12.18282"},{"key":"e_1_2_5_17_1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/oxfordjournals.aje.a113044","article-title":"The need for serologic evaluation of immunization programs","volume":"112","author":"Evans AS","year":"1980","journal-title":"Am J Epidemiol"},{"key":"e_1_2_5_18_1","first-page":"409","article-title":"Detection of postvaccination mumps virus antibody by neutralization test, enzyme\u2010linked immunosorbent assay and sensitive hemagglutination inhibition test","volume":"31","author":"Fedova D","year":"1987","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57149"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-80-2-399"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17398-4"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25940"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202684109"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.6.464"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.7.743"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05208-11"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380703"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/342972"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-03-0191"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1401"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.7.494"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70286-8"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0790"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2009.0055"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.5.10.9518"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70445-7"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1258\/095646203321264872"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.049"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61248-4"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2003.12.027"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25887"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-3-701"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-238"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn044"},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.18865"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq384"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048807"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.13.4.511-519.2006"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.09.002"},{"key":"e_1_2_5_51_1","first-page":"5","article-title":"HPV: Immune response to infection and vaccination","volume":"20","author":"Stanley M","year":"2010","journal-title":"Infect Agent Cancer"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1086\/591625"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26362"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.12.4344-4348.2001"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0621"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0336"},{"key":"e_1_2_5_57_1","unstructured":"van LierEA GiesbersH DrijfhoutIH de HooghPAAM de MelkerHE.2012. Vaccinatiegraad Rijksvaccinatieprogramma Nederland: Verslagjaar 2012. Rivm Rapport Nr. 201001001. Bilthoven: Rijksinstituut Voor Volksgezondheid En Milieu 2012."},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70101-7"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-03-0166"},{"key":"e_1_2_5_60_1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/cdli.4.2.122-126.1997","article-title":"Prevalence of antibodies to human papillomavirus (HPV) type 16 virus\u2010like particles in relation to cervical HPV infection among college women","volume":"4","author":"Viscidi RP","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_5_61_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1055-9965.283.14.1","article-title":"Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV\u2010positive and HIV\u2010negative women","volume":"14","author":"Viscidi RP","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602088"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1591"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.052381"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22116"},{"key":"e_1_2_5_66_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1542\/peds.56.3.380","article-title":"Long\u2010term follow\u2010up for immunity after monovalent or combined live measles, mumps, and rubella virus vaccines","volume":"56","author":"Weibel RE","year":"1975","journal-title":"Pediatrics"},{"key":"e_1_2_5_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.6.1425"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.5.937"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-1108"},{"key":"e_1_2_5_70_1","first-page":"569","article-title":"Human papilloma viruses and cancer","volume":"43","author":"zur Hausen H","year":"1975","journal-title":"Bibl Haematol"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.23616","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.23616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T18:37:37Z","timestamp":1698691057000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.23616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,30]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1002\/jmv.23616"],"URL":"https:\/\/doi.org\/10.1002\/jmv.23616","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,30]]}}}